These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 25202827)
1. Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6. Wu NL; Huang DY; Tsou HN; Lin YC; Lin WW J Invest Dermatol; 2015 Feb; 135(2):490-498. PubMed ID: 25202827 [TBL] [Abstract][Full Text] [Related]
2. Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells. Huang F; Kao CY; Wachi S; Thai P; Ryu J; Wu R J Immunol; 2007 Nov; 179(10):6504-13. PubMed ID: 17982039 [TBL] [Abstract][Full Text] [Related]
3. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Liu C; Qian W; Qian Y; Giltiay NV; Lu Y; Swaidani S; Misra S; Deng L; Chen ZJ; Li X Sci Signal; 2009 Oct; 2(92):ra63. PubMed ID: 19825828 [TBL] [Abstract][Full Text] [Related]
4. TRAF6-dependent Act1 phosphorylation by the IκB kinase-related kinases suppresses interleukin-17-induced NF-κB activation. Qu F; Gao H; Zhu S; Shi P; Zhang Y; Liu Y; Jallal B; Yao Y; Shi Y; Qian Y Mol Cell Biol; 2012 Oct; 32(19):3925-37. PubMed ID: 22851696 [TBL] [Abstract][Full Text] [Related]
5. HSP27 regulates IL-1 stimulated IKK activation through interacting with TRAF6 and affecting its ubiquitination. Wu Y; Liu J; Zhang Z; Huang H; Shen J; Zhang S; Jiang Y; Luo L; Yin Z Cell Signal; 2009 Jan; 21(1):143-50. PubMed ID: 18950704 [TBL] [Abstract][Full Text] [Related]
6. The tyrosine kinase Syk differentially regulates Toll-like receptor signaling downstream of the adaptor molecules TRAF6 and TRAF3. Lin YC; Huang DY; Chu CL; Lin YL; Lin WW Sci Signal; 2013 Aug; 6(289):ra71. PubMed ID: 23962979 [TBL] [Abstract][Full Text] [Related]
7. IL-17A Increases Multiple Myeloma Cell Viability by Positively Regulating Syk Expression. Wang S; Ma Y; Wang X; Jiang J; Zhang C; Wang X; Jiang Y; Huang H; Hong L Transl Oncol; 2019 Aug; 12(8):1086-1091. PubMed ID: 31174059 [TBL] [Abstract][Full Text] [Related]
8. Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling. Moon G; Kim J; Min Y; Wi SM; Shim JH; Chun E; Lee KY Cell Signal; 2015 Dec; 27(12):2524-33. PubMed ID: 26432169 [TBL] [Abstract][Full Text] [Related]
9. Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression. Xiong Y; Qiu F; Piao W; Song C; Wahl LM; Medvedev AE J Biol Chem; 2011 Mar; 286(10):7905-7916. PubMed ID: 21220427 [TBL] [Abstract][Full Text] [Related]
10. NF-kappaB activator Act1 associates with IL-1/Toll pathway adaptor molecule TRAF6. Kanamori M; Kai C; Hayashizaki Y; Suzuki H FEBS Lett; 2002 Dec; 532(1-2):241-6. PubMed ID: 12459498 [TBL] [Abstract][Full Text] [Related]
11. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. Schwandner R; Yamaguchi K; Cao Z J Exp Med; 2000 Apr; 191(7):1233-40. PubMed ID: 10748240 [TBL] [Abstract][Full Text] [Related]
12. TAK1-binding protein 2 facilitates ubiquitination of TRAF6 and assembly of TRAF6 with IKK in the IL-1 signaling pathway. Kishida S; Sanjo H; Akira S; Matsumoto K; Ninomiya-Tsuji J Genes Cells; 2005 May; 10(5):447-54. PubMed ID: 15836773 [TBL] [Abstract][Full Text] [Related]
14. Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Kanda N; Shibata S; Tada Y; Nashiro K; Tamaki K; Watanabe S Eur J Immunol; 2009 Apr; 39(4):996-1006. PubMed ID: 19350575 [TBL] [Abstract][Full Text] [Related]
15. The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells. Zhou Q; Geahlen RL Oncogene; 2009 Mar; 28(10):1348-56. PubMed ID: 19151749 [TBL] [Abstract][Full Text] [Related]
16. MLN4924 protects against interleukin-17A-induced pulmonary inflammation by disrupting ACT1-mediated signaling. Hao R; Song Y; Li R; Wu Y; Yang X; Li X; Qian F; Ye RD; Sun L Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1070-L1080. PubMed ID: 30892082 [TBL] [Abstract][Full Text] [Related]
17. IL-23/IL-17 immune axis mediates the imiquimod-induced psoriatic inflammation by activating ACT1/TRAF6/TAK1/NF-κB pathway in macrophages and keratinocytes. Chen WC; Wen CH; Wang M; Xiao ZD; Zhang ZZ; Wu CL; Wu R Kaohsiung J Med Sci; 2023 Aug; 39(8):789-800. PubMed ID: 37098777 [TBL] [Abstract][Full Text] [Related]
18. Interleukin (IL)-17A synergistically enhances CC chemokine ligand 20 production in IL-1β-stimulated human gingival fibroblasts. Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T Hum Immunol; 2012 Jan; 73(1):26-30. PubMed ID: 22019504 [TBL] [Abstract][Full Text] [Related]
19. Ellipticine blocks synergistic effects of IL-17A and TNF-α in epithelial cells and alleviates severe acute pancreatitis-associated acute lung injury. Li X; Ye C; Mulati M; Sun L; Qian F Biochem Pharmacol; 2020 Jul; 177():113992. PubMed ID: 32335141 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-17F signaling requires ubiquitination of interleukin-17 receptor via TRAF6. Rong Z; Cheng L; Ren Y; Li Z; Li Y; Li X; Li H; Fu XY; Chang Z Cell Signal; 2007 Jul; 19(7):1514-20. PubMed ID: 17346928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]